DRKS00010872招募中不适用
Prospective validation of the prognostic biomarker CD8+ TEMRA cells for disturbed fracture healing. - BioBone
Charité Universitätsmedizin Berlin / Berlin-Brandenburger Centrum für Regenerative Therapien / Julius Wolff Institut0 个研究点目标入组 800 人开始时间: 2016年7月26日最近更新:
适应症
试验速览
- 阶段
- 不适用
- 状态
- 招募中
- 发起方
- 入组人数
- 800
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Observational
入排标准
- 年龄范围
- 18 Years 至 80 Years（—）
- 性别
- All
入选标准
- •full Age (18+),
- •contractually capable,
- •patient who understand the informed consent + signed consent,
- •fracture of the Long bones,
- •surgery Treatment = osteosynthesis,
- •patient was mobilised before the fracture/surgery occured
排除标准
- •periprothetic fractures,
- •pathological fractures,
- •active Tumor disease,
- •active Tumor therapy/Treatment,
- •HIV, Hepatitis B and/or C positive,
- •drug-dependent person
- •psyschological disease,
- •pregnant or nursing Person,
- •participation in another, parallel running interventional study
研究者
相似试验
已完成
不适用
A study of evaluation to the predictive biomarker of Nivolumab in peripheral blood and pleural effusion.previously treated patients with advanced non-small-cell lung cancerJPRN-UMIN000023873Respiratory Medicine, Allergy and Rheu matic Diseases Osaka University Graduate School of Medicine10
招募中
不适用
Validation of predictive and prognostic markers in upper gastrointestinal cancerpper gastrointestinal cancerJPRN-UMIN000030472Shimane University Faculty of Medicine800
招募中
不适用
Prospective study to identify prognostic markers of pancreatic cancerpancreatic cancerJPRN-UMIN000034022Department of Gastroenterology and Hepatology, Kochi Medical School Hospital, Kochi University150
招募中
不适用
A pilot study to investigate prognostic marker of degeneration from cervical intraepithelial neoplasia to cervix carcinomaC53N87C51N90C52N89Malignant neoplasm of cervix uteriDysplasia of cervix uteriMalignant neoplasm of vulvaOther noninflammatory disorders of vulva and perineumMalignant neoplasm of vaginaOther noninflammatory disorders of vaginaDRKS00024987Carl von Ossietzky Universität/Klinikum Oldenburg; Universitätsklinik für Gynäkologie und Geburtshilfe550
已完成
不适用
Validation study of the prognostic and predictive value of TP53 signature for breast cancer Collateral researchBreast cancerJPRN-UMIN000042055Japan Agency for Medical Research and Development107